Business Description
Apontis Pharma AG
ISIN : DE000A3CMGM5
Share Class Description:
XTER:APPH: Bearer SharesCompare
Compare
Traded in other countries / regions
APPH.Germany IPO Date
2021-05-11Description
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.68 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -0.87 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 1.77 | |||||
| Beneish M-Score | -3.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2 | |||||
| 3-Year EPS without NRI Growth Rate | -112.3 | |||||
| 3-Year Book Growth Rate | 106 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 23.25 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.33 | |||||
| 9-Day RSI | 79.4 | |||||
| 14-Day RSI | 76.86 | |||||
| 6-1 Month Momentum % | -26.56 | |||||
| 12-1 Month Momentum % | 93.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.24 | |||||
| Quick Ratio | 3.14 | |||||
| Cash Ratio | 2.54 | |||||
| Days Inventory | 134.54 | |||||
| Days Sales Outstanding | 12.79 | |||||
| Days Payable | 119 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.31 | |||||
| Operating Margin % | -22.64 | |||||
| Net Margin % | -17.42 | |||||
| FCF Margin % | -24.91 | |||||
| ROE % | -21.39 | |||||
| ROA % | -13.35 | |||||
| ROIC % | -27.98 | |||||
| 3-Year ROIIC % | -94.61 | |||||
| ROC (Joel Greenblatt) % | -223.22 | |||||
| ROCE % | -19.85 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 21.4 | |||||
| PS Ratio | 1.98 | |||||
| PB Ratio | 2.6 | |||||
| Price-to-Tangible-Book | 5.78 | |||||
| EV-to-EBIT | -7.15 | |||||
| EV-to-EBITDA | -9.29 | |||||
| EV-to-Revenue | 1.59 | |||||
| EV-to-FCF | -6.35 | |||||
| Price-to-Net-Current-Asset-Value | 8.34 | |||||
| Earnings Yield (Greenblatt) % | -14.01 | |||||
| FCF Yield % | -12.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apontis Pharma AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 40.632 | ||
| EPS (TTM) (€) | -0.832 | ||
| Beta | 1.45 | ||
| Volatility % | 68.99 | ||
| 14-Day RSI | 76.86 | ||
| 14-Day ATR (€) | 0.185636 | ||
| 20-Day SMA (€) | 9.236 | ||
| 12-1 Month Momentum % | 93.9 | ||
| 52-Week Range (€) | 3.2 - 9.88 | ||
| Shares Outstanding (Mil) | 8.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apontis Pharma AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apontis Pharma AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Apontis Pharma AG Frequently Asked Questions
What is Apontis Pharma AG(XTER:APPH)'s stock price today?
The current price of XTER:APPH is €9.76. The 52 week high of XTER:APPH is €9.88 and 52 week low is €3.20.
When is next earnings date of Apontis Pharma AG(XTER:APPH)?
The next earnings date of Apontis Pharma AG(XTER:APPH) is .
Does Apontis Pharma AG(XTER:APPH) pay dividends? If so, how much?
Apontis Pharma AG(XTER:APPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers